AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 76-100/114
TREATMENT OF AML IN THE ELDERLY - FULL-DOSE VERSUS REDUCED DOSE INDUCTION TREATMENT
Authors: BUCHNER T HIDDEMANN W LOFFLER H FONATSCH C GASSMANN W MASCHMEYER G LUDWIG WD HEYLL A HOSSFELD D SAUERLAND MC HEINECKE A
Citation: T. Buchner et al., TREATMENT OF AML IN THE ELDERLY - FULL-DOSE VERSUS REDUCED DOSE INDUCTION TREATMENT, Blood, 86(10), 1995, pp. 1721-1721
MODULATION OF PROLIFERATIVE ACTIVITY AND INTRACELLULAR ARA-C METABOLISM IN AML BLASTS IN-VIVO BY GM-CSF PRIMING
Authors: JAHNSSTREUBEL G REUTER C UNTERHALT M WORMANN B BUCHNER T HIDDEMANN W
Citation: G. Jahnsstreubel et al., MODULATION OF PROLIFERATIVE ACTIVITY AND INTRACELLULAR ARA-C METABOLISM IN AML BLASTS IN-VIVO BY GM-CSF PRIMING, Blood, 86(10), 1995, pp. 2058-2058
QUALITY-OF-LIFE IN ADULT PATIENTS WITH AML RECEIVING INTENSIVE CHEMOTHERAPY - AN UPDATE
Authors: SCHUMACHER A KESSLER T BUCHNER T VANDELOO T
Citation: A. Schumacher et al., QUALITY-OF-LIFE IN ADULT PATIENTS WITH AML RECEIVING INTENSIVE CHEMOTHERAPY - AN UPDATE, Blood, 86(10), 1995, pp. 2072-2072
PIXY321 AND RHG-CSF SUPERIOR TO RHGM-CSF, RHIL-3 OR RHIL-1-BETA AS GROWTH-FACTORS IN PRIMING AML-COLONY FORMING CELLS FOR ARA-C
Authors: ZUHLSDORF M BRANDT M BUCHNER T
Citation: M. Zuhlsdorf et al., PIXY321 AND RHG-CSF SUPERIOR TO RHGM-CSF, RHIL-3 OR RHIL-1-BETA AS GROWTH-FACTORS IN PRIMING AML-COLONY FORMING CELLS FOR ARA-C, Blood, 86(10), 1995, pp. 2813-2813
AML M4EO WITH PERICENTRIC-INVERSION-16 IS A FAVORABLE SUBTYPE OF ACUTE MYELOID-LEUKEMIA - RESULTS OF 65 PATIENTS TREATED IN THE AMLCG-TRIAL
Authors: HAFERLACH T LOFFLER H GASSMANN W SCHOCH R FONATSCH C SCHOCH C SCHLEGELBERGER B LUDWIG WD BECHER R THIEL E HEINECKE A SAUERLAND MC BUCHNER T
Citation: T. Haferlach et al., AML M4EO WITH PERICENTRIC-INVERSION-16 IS A FAVORABLE SUBTYPE OF ACUTE MYELOID-LEUKEMIA - RESULTS OF 65 PATIENTS TREATED IN THE AMLCG-TRIAL, Blood, 86(10), 1995, pp. 3034-3034
HEMATOPOIETIC GROWTH-FACTORS IN CANCER-TREATMENT
Authors: BUCHNER T
Citation: T. Buchner, HEMATOPOIETIC GROWTH-FACTORS IN CANCER-TREATMENT, Stem cells, 12(3), 1994, pp. 241-252
MODULATION OF INTRACELLULAR METABOLISM OF CYTOSINE-ARABINOSIDE IN ACUTE MYELOID-LEUKEMIA BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
Authors: REUTER C DERLANDWEHR UA SCHLEYER E ZUHLSDORF M AMELING C ROLF C WORMANN B BUCHNER T HIDDEMANN W
Citation: C. Reuter et al., MODULATION OF INTRACELLULAR METABOLISM OF CYTOSINE-ARABINOSIDE IN ACUTE MYELOID-LEUKEMIA BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Leukemia, 8(2), 1994, pp. 217-225
GM-CSF MULTIPLE COURSE PRIMING AND LONG-TERM ADMINISTRATION IN NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA - COMPARISON OF 3 DIFFERENT GM-CSF ROUTES AND SCHEDULES WITH NO GM-CSF
Authors: ROTTMANN R BUCHNER T HIDDEMANN W WORMANN B MASCHMEYER G LUDWIG WD ZUHLSDORF M
Citation: R. Rottmann et al., GM-CSF MULTIPLE COURSE PRIMING AND LONG-TERM ADMINISTRATION IN NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA - COMPARISON OF 3 DIFFERENT GM-CSF ROUTES AND SCHEDULES WITH NO GM-CSF, Onkologie, 17(1), 1994, pp. 58-61
A NOVEL REGIMEN FOR CONSOLIDATION CHEMOTHERAPY IN ADULT ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION
Authors: MASCHMEYER G BUCHNER T HIDDEMANN W GASSMANN W HEINECKE A SAUERLAND MC LOFFLER H HEIT W
Citation: G. Maschmeyer et al., A NOVEL REGIMEN FOR CONSOLIDATION CHEMOTHERAPY IN ADULT ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION, Onkologie, 17(1), 1994, pp. 62-65
CORRELATION OF BLAST CELL PROLIFERATIVE ACTIVITY AND SENSITIVITY TO GM-CSF WITH CLINICAL-RESPONSE TO TAD9 INDUCTION THERAPY IN ACUTE MYELOID
Authors: JAHNSSTREUBEL G REUTER C UNTERHALT M SCHLEYER E WORMANN B BUCHNER T HIDDEMANN W
Citation: G. Jahnsstreubel et al., CORRELATION OF BLAST CELL PROLIFERATIVE ACTIVITY AND SENSITIVITY TO GM-CSF WITH CLINICAL-RESPONSE TO TAD9 INDUCTION THERAPY IN ACUTE MYELOID, Experimental hematology, 22(8), 1994, pp. 772-772
NEW PERSPECTIVES IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA BY HEMATOPOIETIC GROWTH-FACTORS
Authors: HIDDEMANN W WORMANN B REUTER C SCHLEYER E ZUHLSDORF M BOCKMANN A BUCHNER T
Citation: W. Hiddemann et al., NEW PERSPECTIVES IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA BY HEMATOPOIETIC GROWTH-FACTORS, Seminars in oncology, 21(6), 1994, pp. 33-38
EXPERIMENTAL BASIS FOR THE USE OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
Authors: WORMANN B REUTER C ZUHLSDORF M BUCHNER T HIDDEMANN W
Citation: B. Wormann et al., EXPERIMENTAL BASIS FOR THE USE OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Seminars in oncology, 21(6), 1994, pp. 39-43
GM-CSF MULTIPLE COURSE PRIMING AND LONG-TERM ADMINISTRATION IN NEWLY-DIAGNOSED AML HEMATOLOGIC AND THERAPEUTIC EFFECTS
Authors: BUCHNER T HIDDEMANN W WORMANN B ROTTMANN R ZUHLSDORF M MASCHMEYER G LUDWIG WD SAUERLAND MC FRISCH J SCHULZ G
Citation: T. Buchner et al., GM-CSF MULTIPLE COURSE PRIMING AND LONG-TERM ADMINISTRATION IN NEWLY-DIAGNOSED AML HEMATOLOGIC AND THERAPEUTIC EFFECTS, Blood, 84(10), 1994, pp. 10000027-10000027
DOUBLE INDUCTION STRATEGY IN AML COMPARING HIGH WITH STANDARD-DOSE ARA-C - HEMATOTOXICITY AND ANTILEUKEMIC EFFICACY
Authors: BUCHNER T HIDDEMANN W LOFFLER H GASSMANN W MASCHMEYER G LUDWIG WD AUL C LENGFELDER E BOECKMANN A SAUERLAND MC HEINECKE A
Citation: T. Buchner et al., DOUBLE INDUCTION STRATEGY IN AML COMPARING HIGH WITH STANDARD-DOSE ARA-C - HEMATOTOXICITY AND ANTILEUKEMIC EFFICACY, Blood, 84(10), 1994, pp. 10000232-10000232
LEUKEMIA ASSOCIATED EXPRESSION PATTERNS OF DIFFERENTIATION ANTIGENS IN ACUTE LYMPHOBLASTIC-LEUKEMIA FOR MONITORING OF MINIMAL RESIDUAL DISEASE BY MULTIPARAMETER FLOW-CYTOMETRY
Authors: GRIESINGER F FALK M PIRONOACK M RITTER J BUCHNER T HIDDEMANN W TERSTAPPEN LWMM WORMANN B
Citation: F. Griesinger et al., LEUKEMIA ASSOCIATED EXPRESSION PATTERNS OF DIFFERENTIATION ANTIGENS IN ACUTE LYMPHOBLASTIC-LEUKEMIA FOR MONITORING OF MINIMAL RESIDUAL DISEASE BY MULTIPARAMETER FLOW-CYTOMETRY, Blood, 84(10), 1994, pp. 10000300-10000300
EARLY EMPIRIC ANTIFUNGAL TREATMENT OF INFECTIONS IN NEUTROPENIC PATIENTS COMPARING FLUCONAZOLE (FCA) WITH AMPHOTERICIN-B 5-FLUCYTOSINE (ABF)/
Authors: SILLINGENGELHARDT G FEGELER W ROOS N SCHOMAKER R ESSINK M BUCHNER T
Citation: G. Sillingengelhardt et al., EARLY EMPIRIC ANTIFUNGAL TREATMENT OF INFECTIONS IN NEUTROPENIC PATIENTS COMPARING FLUCONAZOLE (FCA) WITH AMPHOTERICIN-B 5-FLUCYTOSINE (ABF)/, Blood, 84(10), 1994, pp. 10000306-10000306
CYTOMORPHOLOGICAL FEATURES AND PROGNOSTIC FACTORS IN 33 PATIENTS WITHACUTE MYELOID-LEUKEMIA (AML) AND TRANSLOCATION (8 21)
Authors: HAFERLACH T LOFFLER H GASSMANN W BENNETT JM LUDWIG WD MASCHMEYER G THIEL E NOWROUSIAN MR LANG R KUBICA U WEISS A LENGFELDER E KOCH P WEH HJ TIRIER C SAUERLAND MC HEINECKE A BUCHNER T
Citation: T. Haferlach et al., CYTOMORPHOLOGICAL FEATURES AND PROGNOSTIC FACTORS IN 33 PATIENTS WITHACUTE MYELOID-LEUKEMIA (AML) AND TRANSLOCATION (8 21), Blood, 84(10), 1994, pp. 10000308-10000308
CART - A METHOD TO DETECT PROGNOSTIC SUBGROUPS IN AML
Authors: HEINECKE A SAUERLAND MC BUCHNER T
Citation: A. Heinecke et al., CART - A METHOD TO DETECT PROGNOSTIC SUBGROUPS IN AML, Blood, 84(10), 1994, pp. 10000310-10000310
IMPAIRMENT OF ARTERIAL OXYGEN PARTIAL-PRESSURE (PAO2) DURING THE 1ST 24H OF RH GM-CSF PRIMING IN AML PATIENTS
Authors: ZUHLSDORF M VONEIFF M HIDDEMANN W BUCHNER T
Citation: M. Zuhlsdorf et al., IMPAIRMENT OF ARTERIAL OXYGEN PARTIAL-PRESSURE (PAO2) DURING THE 1ST 24H OF RH GM-CSF PRIMING IN AML PATIENTS, Blood, 84(10), 1994, pp. 10000588-10000588
THE ROLE OF GM-CSF IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA
Authors: BUCHNER T HIDDEMANN W WORMANN B ROTTMANN R MASCHMEYER G LUDWIG WD ZUHLSDORF M BUNTKIRCHEN K SANDER A ASWALD J BINDER I PRISETT S SAUERLAND MC
Citation: T. Buchner et al., THE ROLE OF GM-CSF IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA, Leukemia & lymphoma, 11, 1993, pp. 21-24
CLINICAL ASPECTS OF ACUTE MYELOID LEUKEMIAS OF THE FAB TYPE-M3 AND TYPE-M4EO
Authors: HAFERLACH T GASSMANN W LOFFLER H JURGENSEN C NOAK J LUDWIG WD THIEL E HAASE D FONATSCH C BECHER R SCHLEGELBERGER B NOWROUSIAN MR LENGFELDER E EIMERMACHER H WEH HJ BRAUMANN D MASCHMEYER G KOCH P HEINECKE A SAUERLAND MC BUCHNER T
Citation: T. Haferlach et al., CLINICAL ASPECTS OF ACUTE MYELOID LEUKEMIAS OF THE FAB TYPE-M3 AND TYPE-M4EO, Annals of hematology, 66(4), 1993, pp. 165-170
FOLLOW-UP OF THE 1ST 2 SUCCESSIVE GERMAN MULTICENTER TRIALS FOR ADULTALL (01 81 AND 02/84)/
Authors: HOELZER D THIEL E LUDWIG WD LOFFLER H BUCHNER T FREUND M HEIL G HIDDEMANN W MASCHMEYER G VOLKERS B GOKBUGET N AYDEMIR U
Citation: D. Hoelzer et al., FOLLOW-UP OF THE 1ST 2 SUCCESSIVE GERMAN MULTICENTER TRIALS FOR ADULTALL (01 81 AND 02/84)/, Leukemia, 7, 1993, pp. 190000130-190000134
SUBCUTANEOUS LOW-DOSE ARABINOSYL-CYTOSINE AND ORAL IDARUBICIN IN HIGH-RISK ADULT ACUTE MYELOGENOUS LEUKEMIA
Authors: KUSNIERZGLAZ CR NORMANN D WEINBERG R FUCHS R FLASSHOVE M HIDDEMANN W VANDELOO J BUCHNER T
Citation: Cr. Kusnierzglaz et al., SUBCUTANEOUS LOW-DOSE ARABINOSYL-CYTOSINE AND ORAL IDARUBICIN IN HIGH-RISK ADULT ACUTE MYELOGENOUS LEUKEMIA, Hematological oncology, 11(2), 1993, pp. 73-80
ACUTE MYELOID-LEUKEMIA (VOL 34, PG 511, 1 993)
Authors: BUCHNER T
Citation: T. Buchner, ACUTE MYELOID-LEUKEMIA (VOL 34, PG 511, 1 993), Der Internist, 34(8), 1993, pp. 780-780
ACUTE MYELOID-LEUKEMIA
Authors: BUCHNER T
Citation: T. Buchner, ACUTE MYELOID-LEUKEMIA, Der Internist, 34(6), 1993, pp. 511-517
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>